Feature of Reflex Pathway Activated by WBV and Voluntary Contraction

Is the Reflex Pathway Activated by Whole-body Vibration Change in Case of Voluntary Contraction?

Whole-body vibration (WBV) has beneficial neuromuscular effects on muscle strength increase. Supraspinal, spinal, and peripheral mechanisms have been proposed to explain these beneficial effects. The most commonly proposed explanatory mechanism is spinal segmental reflexes. However, the neuronal circuit and receptors of the reflex response have not been defined precisely. A group of researchers found that the reflex system is the Tonic vibration reflex (TVR) under the neuromuscular effects of WBV; Other researchers claim that WBV activates a different spinal reflex than TVR.

Tonic vibration reflex is a polysynaptic reflex that occurs as a result of muscle spindle activation, in which more than 100 Hz vibrations are applied to the belly or tendon of the muscle.

A group of researchers argues that WBV activates the spinal reflex response, but this reflex response is different from TVR. According to them, WBV-induced reflex (WBV-IR) response latency is longer than TVR latency. WBV activates TVR at very attenuated amplitude; WBV activates a different spinal reflex with longer latency at medium and high amplitude vibration. They reported that although the H-reflex, T-reflex, and TVR latency was longer in the spastic soleus muscle than normotonic soleus muscle, where the muscle spindle and Ia afferent pathway were hyperactive. However, the WBV-IR latency was similar in both spastic and normotonic soleus muscle.

According to hypothesis of the present study , the reflex system activated by WBV changes depending on whether there is voluntary contraction or not: if the vibration is applied during voluntary contraction, the tonic vibration reflex is activated; In the absence of voluntary contraction (when the muscle is at rest), the bone myoregulation reflex is activated. The purpose of this research is to test this hypothesis.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Subjects will be performed WBV in a semi-squatting position and standing upright, and soleus reflex latency will be detected by surface EMG during WBV. TVR latency will be measured by performing Achilles tendon vibration. Achilles tendon reflex latency will also be measured.

The WBV will be applied with the PowerPlate® Pro5 (London UK). The vibration amplitude will be 4 mm. The vibration frequency will be 30, 35, 40 Hz. Each vibration frequency will be applied for the 30s. A 10s rest period will be applied between vibrations of 30 seconds. This test vibration application will be performed in a semi-squatting position and standing upright. Subjects will be administered WBV for familiarisation prior to administration of WBV for testing purposes.

A surface EMG recording will be taken from the right soleus muscle belly. A pair of self-adhesive Ag/AgCl (KENDALL® Covidien, Massachusetts, USA) self-adhesive electrodes will have adhered to the skin. The surface EMG recordings will be made with a PowerLab ® (ADInstruments ADInstruments, Oxford, UK) data recorder with a sample rate of 40 kHz. EMG recordings will be analyzed offline with LabChart7 Pro® version 7.3.8 (ADInstruments, Oxford, UK).

For reflex latency calculation, piezo-electric accelerometers (LIS344ALH, ECOPACK®, Mansfield, TX, USA) will be fixed on the WBV device platform and on the right Achilles tendon. The acceleration data will be recorded with the PowerLab (ADInstruments London) data acquisition simultaneously with the EMG recording. Acceleration recording will be made with a sample rate of 40 kHz.

An electronic reflex hammer (Elcon, Germany) was used to determine T-reflex latency.

WBV-IMR and TVR latencies were then calculated by using the cumulative average method. All latencies were normalized to the body height of each participant. Latency was expressed as milliseconds (ms).

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey, 34173
        • Istanbul Physical Medicine Rehabilitation Training & Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 45 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Being healthy
  • Being a young adult (20-45 years old)
  • Volunteer

Exclusion Criteria:

  • Scar, dermatitis, etc. in the skin tissue where the surface EMG electrode will be placed
  • Kidney stone history
  • Fracture in the lower extremity, history of orthopedic surgery
  • Heart disease, Hypertension
  • Dizziness
  • Metabolic bone diseases, including osteoporosis
  • History of bone occupying lesion, neoplasia, osteomyelitis
  • Degenerative, inflammatory diseases of the joints of the lower extremities
  • Lower extremity thrombophlebitis
  • Lower extremity motor loss, sensory loss, muscle atrophy
  • Subjects who cannot tolerate whole-body vibration

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Vibration
Vibration (WBV and Tendon vibration) will be applied to participants
whole-body vibration and soleus tendon vibration will be applied to participants

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
WBV-IR latency
Time Frame: 1 day
Whole-body vibration induced reflex latency
1 day
TVR latency
Time Frame: 1 day
Tonic vibration reflex latency
1 day
T-reflex latency
Time Frame: 1 day
The Achilles tendon reflex latency
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: İLHAN KARACAN, Istanbul Physical Medicine Rehabilitation Training & Research Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 16, 2021

Primary Completion (Actual)

December 22, 2021

Study Completion (Actual)

December 22, 2021

Study Registration Dates

First Submitted

December 16, 2021

First Submitted That Met QC Criteria

February 2, 2022

First Posted (Actual)

February 3, 2022

Study Record Updates

Last Update Posted (Actual)

February 3, 2022

Last Update Submitted That Met QC Criteria

February 2, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • TVRBMR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vibration; Exposure

Clinical Trials on vibration

Subscribe